Worldwide Epidemiology of Atrial Fibrillation: A Global Burden of Disease, Study. Circulation, vol.129, pp.837-884, 2010. ,
Temporal Trends in Incidence, Prevalence, and Mortality of Atrial Fibrillation in Primary Care, J Am Heart Assoc, vol.6, p.5155, 2017. ,
Epidemiology of atrial fibrillation in France: Extrapolation of international epidemiological data to France and analysis of French hospitalization data, Arch Cardiovasc Dis, vol.104, pp.115-139, 2011. ,
A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study, Am J Med, vol.113, pp.359-64, 2002. ,
Increased risk of cognitive and functional decline in patients with atrial fibrillation: results of the ONTARGET and TRANSCEND studies, Can Med Assoc J, vol.184, pp.329-365, 2012. ,
Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study, Eur Heart J, vol.33, pp.1500-1510, 2012. ,
Should all patients undergo transesophageal echocardiography before electrical cardioversion of atrial fibrillation?, J Am Coll Cardiol, vol.23, pp.533-574, 1994. ,
The Left Atrial Appendage: Anatomy, Function, and Noninvasive Evaluation, JACC Cardiovasc Imaging, vol.7, pp.1251-65, 2014. ,
Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation, Ann Thorac Surg, vol.61, issue.95, p.887, 1996. ,
ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS, Eur Heart J, vol.37, pp.2893-962, 2016. ,
Impact of Left Atrial Appendage Closure During Cardiac Surgery on the Occurrence of Early Postoperative Atrial Fibrillation, Stroke, and Mortality: A Propensity Score-Matched Analysis of 10 633 Patients, Circulation, vol.135, pp.366-78, 2017. ,
Rationale and design of the Left Atrial Appendage Occlusion Study, Ann Cardiothorac Surg, vol.3, p.11, 2014. ,
Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial, Lancet, vol.374, p.9, 2009. ,
Prospective Randomized Evaluation of the Watchman Left Atrial Appendage Closure Device in Patients With Atrial Fibrillation Versus Long-Term Warfarin Therapy, J Am Coll Cardiol, vol.64, pp.1-12, 2014. ,
Evaluating Real-World Clinical Outcomes in Atrial Fibrillation Patients Receiving the WATCHMAN Left Atrial Appendage Closure Technology: Final 2-Year Outcome Data of the EWOLUTION Trial Focusing on History of Stroke and Hemorrhage, Circ Arrhythm Electrophysiol, vol.12, p.6841, 2019. ,
EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion -an update, EuroIntervention, vol.15, pp.1133-1180, 2020. ,
Percutaneous left atrial appendage closure followed by single antiplatelet therapy: Short-and mid-term outcomes, Arch Cardiovasc Dis, vol.110, pp.242-251, 2017. ,
Left Atrial Appendage Occlusion in High Bleeding Risk Patients, J Interv Cardiol, p.6704031, 2019. ,
Transcatheter left atrial appendage occlusion in patients with atrial fibrillation and a high bleeding risk using aspirin alone for postimplant antithrombotic therapy, EuroIntervention, vol.12, pp.2075-82, 2017. ,
Temporal Trends in Incidence, Prevalence, and Mortality of Atrial Fibrillation in Primary Care, J Am Heart Assoc, vol.6, p.5155, 2017. ,
ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS, Eur Heart J, vol.37, pp.2893-962, 2016. ,
Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial, Lancet, vol.374, p.61343, 2009. ,
Prospective Randomized Evaluation of the Watchman Left Atrial Appendage Closure Device in Patients With Atrial Fibrillation Versus Long-Term Warfarin Therapy, J Am Coll Cardiol, vol.64, pp.1-12, 2014. ,
Evaluating Real-World Clinical Outcomes in Atrial Fibrillation Patients Receiving the WATCHMAN Left Atrial Appendage Closure Technology: Final 2-Year Outcome Data of the EWOLUTION Trial Focusing on History of Stroke and Hemorrhage, Circ Arrhythm Electrophysiol, vol.12, p.6841, 2019. ,
EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion -an update, EuroIntervention, vol.15, pp.1133-80, 2020. ,
Percutaneous left atrial appendage occlusion: the Munich consensus document on definitions, endpoints and data collection requirements for clinical studies, EuroIntervention, vol.12, pp.103-114, 2016. ,
Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-Year follow-up outcome data of the EWOLUTION trial, Heart Rhythm, vol.14, pp.1302-1310, 2017. ,
Interventional occlusion of left atrial appendage in patients with atrial fibrillation, J Interv Card Electrophysiol Published Online First, 2019. ,
Real-world safety and efficacy of WATCHMAN LAA closure at one year in patients on dual antiplatelet therapy: results of the DAPT subgroup from the EWOLUTION all-comers study, EuroIntervention, vol.13, pp.2003-2014, 2018. ,
Device-Related Thrombosis After Percutaneous Left Atrial Appendage Occlusion for Atrial Fibrillation, J Am Coll Cardiol, vol.71, pp.1528-1564, 2018. ,
Transcatheter left atrial appendage occlusion in patients with atrial fibrillation and a high bleeding risk using aspirin alone for postimplant antithrombotic therapy, EuroIntervention, vol.12, pp.2075-82, 2017. ,
Left Atrial Appendage Occlusion in High Bleeding Risk Patients, J Interv Cardiol, p.6704031, 2019. ,
Percutaneous left atrial appendage closure followed by single antiplatelet therapy: Short-and mid-term outcomes, Arch Cardiovasc Dis, vol.110, pp.242-251, 2017. ,
Device-associated thrombus formation after left atrial appendage occlusion: A systematic review of events reported with the Watchman, the Amplatzer Cardiac Plug and the Amulet: Device-Related Thrombosis After LAAO, Catheter Cardio Inte, vol.90, pp.111-132, 2017. ,
Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN, JACC-Cardiovasc Inte, vol.12, pp.1055-63, 2019. ,
Device-Related Thrombus After Left Atrial Appendage Closure: Incidence, Predictors, and Outcomes, Circulation, vol.138, pp.874-85, 2018. ,
Comparative Validation of a Novel Risk Score for Predicting Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation, J Am Coll Cardiol, vol.57, pp.173-80, 2011. ,
Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study, Eur Heart J, vol.33, pp.1500-1510, 2012. ,
Effectiveness of Only Aspirin or Clopidogrel Following Percutaneous Left Atrial Appendage Closure, Am J Cardiol, vol.124, pp.1894-1903, 2019. ,
Short-term dual antiplatelet therapy after interventional left atrial appendage closure with different devices, EuroIntervention, vol.13, pp.2138-2184, 2018. ,
Left atrial appendage occlusion with the AmplatzerTM AmuletTM device: full results of the prospective global observational study, Eur Heart J, vol.169, pp.1-8, 2020. ,